Immediate Impact
1 by Nobel laureates 53 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
The Role of Brain-Derived Neurotrophic Factor as an Essential Mediator in Neuronal Functions and the Therapeutic Potential of Its Mimetics for Neuroprotection in Neurologic and Psychiatric Disorders
2025 Standout
Works of Ryan Geschwindt being referenced
Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours
2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ryan Geschwindt | 77 | 137 | 93 | 15 | 328 | |
| Ya-Li Zhai | 44 | 91 | 68 | 11 | 352 | |
| Geoff Watson | 184 | 50 | 90 | 17 | 367 | |
| Wan Sun | 147 | 143 | 49 | 24 | 310 | |
| Tatsuo Iizumi | 67 | 117 | 122 | 20 | 299 | |
| Angèle L.M. Oei | 99 | 55 | 74 | 14 | 361 | |
| Andre M. Kallab | 88 | 65 | 62 | 17 | 278 | |
| Masae Matsumoto | 83 | 75 | 71 | 16 | 304 | |
| Francisco Torrubia | 38 | 114 | 175 | 12 | 342 | |
| Maurice M. Albala | 80 | 58 | 54 | 21 | 295 | |
| Sarah Benafif | 126 | 161 | 130 | 23 | 346 |
All Works
Loading papers...